Massoud, R., Flossdorf, S., Hanke, F., Schroeder, T., Bethge, W., Zeiser, R., Pabst, C., Wulf, G., Sala, E., Hilgendorf, I., Scheid, C., Edinger, M., Stölzel, F., Blau, I. W., Stelljes, M., Kobbe, G., Platzbecker, U., Bittenbring, J. T., Eder, M., Fleischhauer, K., Burchert, A., Schmid, C. and Kröger, N. (2020) “Impact of FMS-like tyrosine kinase 3 inhibitor maintenance on post-transplant outcomes in acute myeloid leukemia with FMS-like tyrosine kinase 3 mutations: a real-world German registry analysis highlighting sorafenib”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2025.300176.